352 related articles for article (PubMed ID: 30137309)
1. Chemokines and Chemokine Receptors as Therapeutic Targets in Inflammatory Bowel Disease; Pitfalls and Promise.
Trivedi PJ; Adams DH
J Crohns Colitis; 2018 Aug; 12(suppl_2):S641-S652. PubMed ID: 30137309
[TBL] [Abstract][Full Text] [Related]
2. Chemokines as novel therapeutic targets for inflammatory bowel disease.
Nishimura M; Kuboi Y; Muramoto K; Kawano T; Imai T
Ann N Y Acad Sci; 2009 Sep; 1173():350-6. PubMed ID: 19758172
[TBL] [Abstract][Full Text] [Related]
3. Expression and role of CCR6/CCL20 chemokine axis in pulmonary sarcoidosis.
Facco M; Baesso I; Miorin M; Bortoli M; Cabrelle A; Boscaro E; Gurrieri C; Trentin L; Zambello R; Calabrese F; Cassatella MA; Semenzato G; Agostini C
J Leukoc Biol; 2007 Oct; 82(4):946-55. PubMed ID: 17615381
[TBL] [Abstract][Full Text] [Related]
4. Decreased circulating CXCR3 + CCR9+T helper cells are associated with elevated levels of their ligands CXCL10 and CCL25 in the salivary gland of patients with Sjögren's syndrome to facilitate their concerted migration.
Blokland SLM; Kislat A; Homey B; Smithson GM; Kruize AA; Radstake TRDJ; van Roon JAG
Scand J Immunol; 2020 Mar; 91(3):e12852. PubMed ID: 31733111
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte homing antagonists in the treatment of inflammatory bowel diseases.
Saruta M; Papadakis KA
Gastroenterol Clin North Am; 2014 Sep; 43(3):581-601. PubMed ID: 25110260
[TBL] [Abstract][Full Text] [Related]
6. Chemokine Signaling in Allergic Contact Dermatitis: Toward Targeted Therapies.
Smith JS; Rajagopal S; Atwater AR
Dermatitis; 2018; 29(4):179-186. PubMed ID: 29939854
[TBL] [Abstract][Full Text] [Related]
7. Quantification of chemokine and chemokine receptor gene expression in duodenal mucosa of dogs with inflammatory bowel disease.
Maeda S; Ohno K; Nakamura K; Uchida K; Nakashima K; Fukushima K; Tsukamoto A; Goto-Koshino Y; Fujino Y; Tsujimoto H
Vet Immunol Immunopathol; 2011 Dec; 144(3-4):290-8. PubMed ID: 21996024
[TBL] [Abstract][Full Text] [Related]
8. CCR6 and CCL20: partners in intestinal immunity and lymphorganogenesis.
Williams IR
Ann N Y Acad Sci; 2006 Aug; 1072():52-61. PubMed ID: 17057190
[TBL] [Abstract][Full Text] [Related]
9. CC chemokine receptor 6 (CCR6) in the pathogenesis of systemic lupus erythematosus.
Lee AY; Körner H
Immunol Cell Biol; 2020 Nov; 98(10):845-853. PubMed ID: 32634857
[TBL] [Abstract][Full Text] [Related]
10. Expression and functional activity of chemokine receptors in glatiramer acetate-specific T cells isolated from multiple sclerosis patient receiving the drug glatiramer acetate.
Høglund RA; Hestvik AL; Holmøy T; Maghazachi AA
Hum Immunol; 2011 Feb; 72(2):124-34. PubMed ID: 20977917
[TBL] [Abstract][Full Text] [Related]
11. Description of B lymphocytes and plasma cells, complement, and chemokines/receptors in acute liver allograft rejection.
Krukemeyer MG; Moeller J; Morawietz L; Rudolph B; Neumann U; Theruvath T; Neuhaus P; Krenn V
Transplantation; 2004 Jul; 78(1):65-70. PubMed ID: 15257040
[TBL] [Abstract][Full Text] [Related]
12. Chemokines in inflammatory bowel disease.
Papadakis KA
Curr Allergy Asthma Rep; 2004 Jan; 4(1):83-9. PubMed ID: 14680627
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of CCL20 in human inflammatory bowel disease.
Kaser A; Ludwiczek O; Holzmann S; Moschen AR; Weiss G; Enrich B; Graziadei I; Dunzendorfer S; Wiedermann CJ; Mürzl E; Grasl E; Jasarevic Z; Romani N; Offner FA; Tilg H
J Clin Immunol; 2004 Jan; 24(1):74-85. PubMed ID: 14997037
[TBL] [Abstract][Full Text] [Related]
14. CCR9+ T cells contribute to the resolution of the inflammatory response in a mouse model of intestinal amoebiasis.
Rojas-López AE; Soldevila G; Meza-Pérez S; Dupont G; Ostoa-Saloma P; Wurbel MA; Ventura-Juárez J; Flores-Romo L; García-Zepeda EA
Immunobiology; 2012 Aug; 217(8):795-807. PubMed ID: 22633147
[TBL] [Abstract][Full Text] [Related]
15. Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease.
Walters MJ; Wang Y; Lai N; Baumgart T; Zhao BN; Dairaghi DJ; Bekker P; Ertl LS; Penfold ME; Jaen JC; Keshav S; Wendt E; Pennell A; Ungashe S; Wei Z; Wright JJ; Schall TJ
J Pharmacol Exp Ther; 2010 Oct; 335(1):61-9. PubMed ID: 20660125
[TBL] [Abstract][Full Text] [Related]
16. Increased CXCR3+ T Cells Impairs Recruitment of T-Helper Type 17 Cells via Interferon γ and Interleukin 18 in the Small Intestine Mucosa During Treated HIV-1 Infection.
Loiseau C; Requena M; Nayrac M; Mavigner M; Cazabat M; Iscache AL; Carrere N; Suc B; Alric L; Izopet J; Delobel P
J Infect Dis; 2019 Jul; 220(5):830-840. PubMed ID: 30880342
[TBL] [Abstract][Full Text] [Related]
17. [Treatment for rheumatoid arthritis by chemokine blockade].
Nanki T
Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(3):172-80. PubMed ID: 27320932
[TBL] [Abstract][Full Text] [Related]
18. CCL20 is a novel ligand for the scavenging atypical chemokine receptor 4.
Matti C; D'Uonnolo G; Artinger M; Melgrati S; Salnikov A; Thelen S; Purvanov V; Strobel TD; Spannagel L; Thelen M; Legler DF
J Leukoc Biol; 2020 Jun; 107(6):1137-1154. PubMed ID: 32533638
[TBL] [Abstract][Full Text] [Related]
19. Chemokine/chemokine receptor pair CCL20/CCR6 in human colorectal malignancy: An overview.
Frick VO; Rubie C; Keilholz U; Ghadjar P
World J Gastroenterol; 2016 Jan; 22(2):833-41. PubMed ID: 26811629
[TBL] [Abstract][Full Text] [Related]
20. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites.
Dieu MC; Vanbervliet B; Vicari A; Bridon JM; Oldham E; Aït-Yahia S; Brière F; Zlotnik A; Lebecque S; Caux C
J Exp Med; 1998 Jul; 188(2):373-86. PubMed ID: 9670049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
